Journal
TRAVEL MEDICINE AND INFECTIOUS DISEASE
Volume 36, Issue -, Pages -Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.tmaid.2020.101632
Keywords
SARS-CoV-2; COVID-19; Travel; Epidemic; Influenza; Coronaviruses
Funding
- National Research Agency under the program Investissements d'avenir [ANR-10-IAHU-03]
- Region Provence Alpes Cote d'Azur
- European funding FEDER PRIMI
- Institut Hospitalo-Universitaire (IHU) Mediterranee Infection
Ask authors/readers for more resources
Background: Rapid virological diagnosis is needed to limit the length of isolation for suspected COVID-19 cases. Method: We managed the first 280 patients suspected to have COVID-19 through a rapid care circuit and virological diagnosis in our infectious disease reference hospital in Marseille, France. Rapid viral detection was performed on sputum and nasopharyngeal samples. Results: Over our study period, no SARS-CoV-2 was detected. Results were obtained within approximately 3 h of the arrival of patient samples at the laboratory. Other viral infections were identified in 49% of the patients, with most common pathogens being influenza A and B viruses, rhinovirus, metapneumovirus and common coronaviruses, notably HKU1 and NL63. Conclusion: Early recognition of COVID-19 is critical to isolate confirmed cases and prevent further transmission. Early rule-out of COVID-19 allows public health containment measures to be adjusted by reducing the time spent in isolation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available